✦ LIBER ✦

T2083 Mutations in Both KRAS and BRAF Contribute to the Methylator Phenotype in Colon Cancer

✍ Scribed by Nagasaka, Takeshi; Koi, Minoru; Nishida, Naoshi; Shin, Sung Kwan; Matsubara, Nagahide; Boland, C.R.; Goel, Ajay

Book ID: 122794273
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 63 KB
Volume: 134
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(08)62873-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mutations in Both KRAS and BRAF May Cont

Mutations in Both KRAS and BRAF May Contribute to the Methylator Phenotype in Colon Cancer

✍ Takeshi Nagasaka; Minoru Koi; Matthias Kloor; Johannes Gebert; Alex Vilkin; Naos 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 1012 KB

Association of Smoking, CpG Island Methy

Association of Smoking, CpG Island Methylator Phenotype, and V600E BRAF Mutations in Colon Cancer

✍ Samowitz, W. S.; Albertsen, H.; Sweeney, C.; Herrick, J.; Caan, B. J.; Anderson, 📂 Article 📅 2006 🏛 Oxford University Press 🌐 English ⚖ 224 KB

Diet and lifestyle factor associations w

Diet and lifestyle factor associations with CpG island methylator phenotype and BRAF mutations in colon cancer

✍ Martha L. Slattery; Karen Curtin; Carol Sweeney; Theodore R. Levin; John Potter; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 104 KB

## Abstract It has been proposed that dietary factors such as folate, alcohol and methionine may be associated with colon cancer because of their involvement in DNA methylation processes. Data from a large population‐based case‐control study of incident colon cancer were used to evaluate whether in

CpG island methylator phenotype, microsa

CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer

✍ Ogino, S.; Nosho, K.; Kirkner, G. J; Kawasaki, T.; Meyerhardt, J. A; Loda, M.; G 📂 Article 📅 2008 🏛 BMJ Publishing Group 🌐 English ⚖ 302 KB

Clinicopathological features of CpG isla

Clinicopathological features of CpG island methylator phenotype-positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutation

✍ Sun Lee; Nam-Yun Cho; Minhee Choi; Eun J. Yoo; Jung-Ho Kim; Gyeong H. Kang 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 241 KB

TRAIL receptor upregulation and the impl

TRAIL receptor upregulation and the implication of KRAS/BRAF mutations in human colon cancer tumors

✍ Eftychia Oikonomou; Vivian Kosmidou; Anastasia Katseli; Konstantinos Kothonidis; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 273 KB 👁 2 views

## Abstract TRAIL raises hopes as a promising anti‐tumor agent due to its selectivity toward cancer cells. Higher expression of its pro‐death receptors TRAIL‐R1 (DR4) and TRAIL‐R2 (DR5) attenuates higher sensitivity to TRAIL‐induced apoptosis, and represents a marker for better cancer prognosis and